GlassScriptPhysician profile
Sarah D Clayton
NPI 1306469564
$1,554.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $542 · 2023: $534 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $651.46 | 2021-2023 | Acessa Provu System, Coolseal Generator |
| Coopersurgical, INC. | $153.20 | 2021-2023 | Summit Doppler |
| Myovant Sciences INC. | $131.06 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Myfembree |
| Axonics, INC. | $124.45 | 2024 | Bulkamid |
| Convatec INC. | $98.87 | 2023 | |
| Therapeuticsmd, INC. | $77.08 | 2021 | |
| Aspira Women'S Health INC | $55.00 | 2023 | Ova1 |
| Organon LLC | $39.28 | 2022-2023 | Nexplanon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.90 | 2021 | |
| Avanos Medical | $21.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.47 | 2021 | |
| Merck Sharp & Dohme LLC | $14.60 | 2023 | Gardasil 9 |
| Abbvie INC. | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.